Trials / Conditions / HER2 Negative Breast Neoplasms
HER2 Negative Breast Neoplasms
4 registered clinical trials studyying HER2 Negative Breast Neoplasms — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors NCT05194072 | Seagen, a wholly owned subsidiary of Pfizer | Phase 1 |
| Terminated | A Study of SGN-STNV in Advanced Solid Tumors NCT04665921 | Seagen Inc. | Phase 1 |
| Recruiting | A Study of Sigvotatug Vedotin in Advanced Solid Tumors NCT04389632 | Seagen, a wholly owned subsidiary of Pfizer | Phase 1 |
| Terminated | A Study of SGN-CD228A in Advanced Solid Tumors NCT04042480 | Seagen Inc. | Phase 1 |